Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | KIT |
| Variant | D816V |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | KIT D816V lies within the tyrosine kinase domain 2 of the Kit protein (PMID: 19865100). D816V results in constitutive phosphorylation of Kit, activation of Stat5 signaling (PMID: 19865100, PMID: 18390729), induces mastocytosis and tumor formation in mice (PMID: 21148330) and confers resistance to Kit inhibitors (PMID: 22301675, PMID: 19164557). |
| Associated Drug Resistance | Y |
| Category Variants Paths |
KIT mutant KIT act mut KIT D816V KIT mutant KIT exon17 KIT D816X KIT D816V |
| Transcript | NM_000222.3 |
| gDNA | chr4:g.54733155A>T |
| cDNA | c.2447A>T |
| Protein | p.D816V |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_005265741.1 | chr4:g.54733155A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| NM_001385290.1 | chr4:g.54733155A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| NM_000222 | chr4:g.54733155A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| NM_001093772.2 | chr4:g.54733167A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| NM_001385292.1 | chr4:g.54733167A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| XM_017008179.1 | chr4:g.54733167A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| NM_000222.3 | chr4:g.54733155A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| XM_017008179 | chr4:g.54733167A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| NM_001093772 | chr4:g.54733167A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| NM_001093772.1 | chr4:g.54733167A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| NM_000222.2 | chr4:g.54733155A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| XM_005265741 | chr4:g.54733155A>T | c.2447A>T | p.D816V | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04910685 | Phase II | Elenestinib | (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis | Recruiting | USA | SWE | NOR | NLD | ITA | GBR | FRA | ESP | DEU | CHE | BEL | AUT | AUS | 1 |